| Market Capitalization (Millions $) |
437 |
| Shares
Outstanding (Millions) |
23 |
| Employees |
44 |
| Revenues (TTM) (Millions $) |
12 |
| Net Income (TTM) (Millions $) |
-314 |
| Cash Flow (TTM) (Millions $) |
17 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Surrozen Inc. is a biotechnology company headquartered in San Francisco, California. It was founded in 2016 and is focused on developing novel therapeutics to regenerate damaged tissues and organs. Surrozen utilizes its proprietary technology platform to discover and develop drugs that target the Wnt signaling pathway, which plays a critical role in tissue repair and regeneration.
The company's therapeutics aim to activate the body's natural regenerative processes by stimulating specific cell types to enhance tissue healing. Surrozen's innovative approach holds potential for treating a wide range of diseases and injuries, including those affecting the liver, lung, and gastrointestinal system.
Surrozen has garnered significant attention and investment from prominent pharmaceutical companies and venture capital firms due to the promising potential of its technology. By leveraging advancements in stem cell biology and regenerative medicine, Surrozen seeks to revolutionize the treatment of various debilitating conditions and improve patient outcomes.
While still in the early stages of development, Surrozen has a strong team of scientists and industry experts dedicated to advancing its pipeline of regenerative therapeutics. The company's ultimate goal is to translate cutting-edge research into transformative therapies that have a profound impact on patients suffering from chronic or acute tissue damage.
Company Address: 171 Oyster Point Blvd South San Francisco 94080 CA
Company Phone Number: 489-9000 Stock Exchange / Ticker: NASDAQ SRZN
|
200 %